Beta Bionics chief commercial officer Mark Hopman reports sale of common shares worth $12,570.50
BBNX•Mark Hopman sold 775 Beta Bionics common shares on Nov. 16, 2026, for $16.22 each, totaling $12,570.50. He exercised options for 775 shares at $5.10 each, leaving 20,950 options and 54,143 directly held shares.
1. Share transactions
Beta Bionics Chief Commercial Officer Mark Hopman sold 775 common shares on Nov. 16, 2026, at $16.22 per share. He also exercised employee stock options for 775 common shares at $5.10 each; after the transactions, he held 20,950 options and 54,143 common shares directly.




